Frederick, Maryland • Business News • Projects • City Updates
Friday, December 19, 2014
AstraZeneca Announced Plans to Expand its Biologics Manufacturing Center in Frederick
2011 Grand Opening
On Friday, November 21, 2014, AstraZeneca announced plans to expand its biologics manufacturing center in Frederick, Md. The more than $200 million project will increase production capacity at the facility to support AstraZeneca’s maturing pipeline, and will help position the company to keep pace with a growing demand for the development and use of biologics, which currently represent nearly 50% of AstraZeneca’s overall pipeline. The expansion is also expected to bring a total of 300 new jobs to Frederick.
“We’re very pleased by AstraZeneca’s demonstrable commitment to our local workforce and to our growing biotech community,” said Frederick City Mayor Randy McClement. “This expansion will help bring even more high-caliber life science jobs and career opportunities to Frederick and the surrounding region.”